CareDx, Inc (CDNA) vs IDEAYA Biosciences, Inc. (IDYA)

A side-by-side comparison of CareDx, Inc and IDEAYA Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CDNA vs IDYA

growth of $100 · dividends reinvested · last 7y
CDNA +110.3% (+11.2%/yr)IDYA +240.1% (+19.1%/yr)IDYA compounded faster over this window
0100200300400Start $100202120232025$210$340
CDNA IDYA

CDNA vs IDYA: by the numbers

  • •IDYA is the larger company ($3.48B vs $3.44B market cap).
  • •CDNA is profitable (24.23% net margin) while IDYA runs a net loss (-74.75%).
  • •IDYA grew revenue faster over the past five years (45.80% vs 12.56% CAGR).

Metrics side by side

Valuation

MetricCDNAIDYA
P/E ratio32.09N/A
Forward P/E55.48N/A
P/S ratio7.5114.87
P/B ratio8.082.90
EV / EBITDA198.20N/A
FCF yield2.47%N/A

Profitability

MetricCDNAIDYA
Gross margin70.58%-43.89%
Operating margin-0.92%-72.84%
Net margin24.23%-74.75%
ROE26.08%-14.60%
ROIC-0.93%-17.68%

Growth (annualized)

MetricCDNAIDYA
Revenue CAGR (5Y)12.56%45.80%
Total return CAGR (5Y)1.33%7.32%

Frequently asked

Which has grown faster, CDNA or IDYA?
Over the past five years, IDYA grew revenue faster — CDNA at a 12.56% CAGR versus IDYA at 45.80%.
Is CDNA or IDYA more profitable?
CDNA runs the higher net margin — CDNA at 24.23% versus IDYA at -74.75%.
How have CDNA and IDYA total returns compared?
Over the past 5 years, CDNA delivered 1.33% and IDYA delivered 7.32% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.